Voyager Therapeutics, Inc. (VYGR) Cash Flow Annual - Discounting Cash Flows
VYGR
Voyager Therapeutics, Inc.
VYGR (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing: 2025-11-10 2025-03-11 2023-12-31 2023-03-07 2022-03-08 2021-02-25 2020-03-03 2019-02-26 2018-03-14 2017-03-15 2016-03-17 2014-12-31 2013-12-31
Net Income/Starting Line -126.8 -65 132.3 -46.41 -71.2 36.74 -43.6 -88.29 -70.7 -40.19 -29.67 -16.32 -7.67
Cash From Operating Activities -116.7 -15.31 77.92 -12.51 -53.52 -96.72 48.67 -15.89 -61.35 -42.48 41.3 -11.92 -5.45
Depreciation and Amortization 2.23 4.73 4.44 6.19 5.17 3.82 2.77 2.12 1.59 0.612 0.6 0.184 0
Deferred Income Tax 0 0 0 0 0 0 0 -2.16 -0.024 0.696 0.452 0 0
Stock Based Compensation 11.54 14.79 11.15 9.34 11.32 14.93 15.64 15.71 9.24 6.31 4.03 0.425 0
Other Non-Cash Items 5.01 -4.68 -3.45 -2.11 -2.11 -7.67 -4.58 1.36 0.674 2.94 9.75 3.31 2.03
Changes in Working Capital -8.74 34.86 -66.56 20.47 3.29 -144.5 78.44 55.38 -2.13 -12.85 56.14 0.477 0.182
Accounts Receivable 15.63 81.31 -83.23 0.475 7.28 10.48 -18.5 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0
Accounts Payable -1.04 2.39 -0.962 1.99 -0.06 -3.44 2.6 -0.282 0.47 -0.062 -0.942 0.604 0
Deferred Revenue -23.33 -48.84 17.64 18 -3.93 -151.6 94.34 55.66 -2.6 -12.79 57.08 -0.127 0.182
Other Working Capital 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities 50.82 -94.86 -141.6 -7.34 65.91 113 -90.48 26.47 -3.68 47.3 -194.8 -3.3 0
Investments in Property Plant and Equipment -2.12 -3.52 -3.26 -2.49 -1.61 -12.1 -7.72 -4.3 -3.98 -5.03 -1.03 -2.99 0
Payments for Acquisitions 0 0 138.4 0 0 0 0 0 0 0 0 0 0
Purchases of Securities -252.4 -465.7 -224 -54.85 -15.12 -70.4 -494.2 -333.2 -147.3 -112.3 -220.4 0 0
Sales and Maturities of Investments 305.4 374.3 85.58 50 82.63 195.5 411.3 364 147.6 165.1 26.66 0 0
Other Investing Activities 0 0 -138.4 0 0 0 0.172 30.77 0.304 -0.421 -193.7 -0.314 0
Cash From Financing Activities 1.25 114 33.65 1.11 0.612 3.16 80.99 4.75 59.92 0.514 177.7 22.12 5.72
Debt Repayment 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock Issued 0.598 112.8 31.12 1.11 0.612 3.16 77.62 4.75 57.99 0.514 104.8 0.08 0
Common Stock Repurchased 0 0 0 0 0 0 0 0.86 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.656 1.24 2.52 0 0 0 3.38 4.75 1.93 0.514 177.7 44.16 5.72
Effect of Forex Changes on Cash -2.74 0 0 0.264 0 -1.04 0 0 0 0 0 0 0
Net Change in Cash -29.12 3.85 -30.08 -18.47 12.99 18.4 39.18 15.33 -5.11 5.33 24.27 6.9 0.27
Cash at Beginning of Period 74.24 70.39 100.5 117.4 104.4 86.04 47.59 32.27 36.64 31.31 7.04 0.135 0
Cash at End of Period 45.12 74.24 70.39 98.96 117.4 104.4 86.78 47.59 31.53 36.64 31.31 7.04 0.27
Free Cash Flow -118.9 -18.83 74.66 -15 -55.13 -108.8 40.95 -20.19 -65.33 -47.51 40.27 -14.91 -5.45
Operating Cash Flow -116.7 -15.31 77.92 -12.51 -53.52 -96.72 48.67 -15.89 -61.35 -42.48 41.3 -11.92 -5.45
Capital Expenditure -2.12 -3.52 -3.26 -2.49 -1.61 -12.1 -7.72 -4.3 -3.98 -5.03 -1.03 -2.99 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program